$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Detailed instructions for valganciclovir/vansevir: indications and medication precautions
2026-02-01 22:25:32
Check Details
Guide to taking Aprecitentan (Tryvio): Dosing times and dosage instructions
2026-02-01 22:25:32
Check Details
Is the loss of weight caused by the injection of Tilpotide/Mufenda due to the weakening of hunger?
2026-02-01 22:25:32
Check Details
Differences and characteristics between pitubrutinib/zeparib and zanubrutinib
2026-02-01 22:25:32
Check Details
Price comparison of capmatinib, a new drug for the treatment of MET-mutated non-small cell lung cancer, in different countries
2026-02-01 22:25:32
Check Details
Price Differences and Buying Guide of Different Versions of Generic Drugs of Pralsetinib
2026-02-01 22:25:32
Check Details
There are several generic versions of capmatinib currently available on the market.
2026-02-01 22:25:32
Check Details
R&D progress and launch time of the domestic targeted drug Sotorasib (AMG 510) (Sotorasib)
2026-02-01 22:25:32
Check Details
Is there currently a domestic version of adagrasib (Krazati) and an introduction to the progress of localization
2026-02-01 22:25:32
Check Details
Can larotrectinib (Vitaika) be used safely in pediatric patients and its dosage reference
2026-02-01 22:25:32
Check Details
Precautions and risks of sudden discontinuation of Seleniso (Silvio) after taking it for six days
2026-02-01 22:25:32
Check Details
How long should children with spasticity take Vigabatrin (Ocoda)?
2026-02-01 22:25:32
Check Details
1
2
...
1915
1916
1917
1918
1919
1920
1921
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
2
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
3
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
4
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
5
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
6
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
7
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment
8
Enasidenib (IDHIFA): A Comprehensive Guide to Targeted Therapy for IDH2-Mutated Acute Myeloid Leukemia
9
Midostaurin vs. Gilteritinib: Key Differences in FLT3-Targeted AML Therapy
10
Lapatinib: A Targeted Anticancer Agent — Not Merely Symptom Relief
11
Filgotinib: Mechanism of Action and Clinical Applications Explained
12
Lapatinib: Proper Administration Guide and Key Precautions